Tirzepatide Weight Loss Injections in Naperville, IL

When other weight loss approaches have fallen short, tirzepatide offers a measurably different path. It is the first injectable weight loss medication to activate two hormone pathways at once, producing greater average weight loss than any previously approved medication in its class. As part of our Weight Loss Services at Naperville Internist, Dr. Rakesh Marwaha and Dr. Rachit Marwaha prescribe tirzepatide for eligible adults in Naperville, IL.

What Is Tirzepatide?

Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, the first medication in its class to target both hormone pathways simultaneously. GLP-1-only therapies have an established track record, but adding GIP receptor activation amplifies those effects: appetite suppression is stronger, insulin sensitivity improves through two mechanisms at once, and blood sugar regulation benefits from both pathways working together. Administered as a once-weekly subcutaneous injection, tirzepatide has produced average weight reductions of 20 to 22 percent of total body weight in large-scale clinical trials, outperforming every earlier GLP-1 therapy studied.

Is Tirzepatide Right for You:

Tirzepatide is FDA-approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher when accompanied by at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or obstructive sleep apnea. It is not appropriate for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or a history of pancreatitis. Your physician will review your full medical history at your first appointment before any recommendation is made.

How Tirzepatide Treatment Works at Naperville Internist

Comprehensive assessment. Your first visit includes a full physical exam and medical history review to confirm tirzepatide is safe and appropriate for you before any prescription is written.
Personalized dosing plan. Dr. Rakesh or Dr. Rachit Marwaha builds a protocol specific to your health profile, starting at a low dose and escalating gradually to minimize side effects during the adjustment period.
Injection training. Our clinical team walks you through proper self-injection technique so you can administer your weekly dose at home with confidence.
Ongoing monitoring. Regular follow-up appointments track your progress and labs, and allow your physician to adjust your dose as your response to treatment evolves.

Concurrent care. As a full internal medicine practice, Naperville Internist can evaluate and manage related conditions such as hypertension, pre-diabetes, and elevated cholesterol without additional referrals.

Benefits of Tirzepatide for Weight Loss

Tirzepatide’s primary advantage over earlier weight loss medications is the degree of results it produces. Patients in large-scale trials achieved average reductions of 20 to 22 percent of total body weight when combining treatment with dietary and lifestyle changes, results that exceed those seen with GLP-1-only therapies. The dual mechanism makes sustained appetite control more achievable by working through two pathways rather than one. Many patients also see measurable improvements in blood sugar, blood pressure, and cholesterol alongside their weight loss, giving tirzepatide broad metabolic value beyond the scale.

Comparing Tirzepatide and Semaglutide

Naperville Internist offers both semaglutide and tirzepatide injections in Naperville, each designed to support weight loss and metabolic health. Semaglutide works by targeting a single hormone (GLP-1), helping reduce appetite and improve blood sugar control, while tirzepatide targets two hormones (GLP-1 and GIP), which may lead to greater appetite suppression and weight loss for some patients. Both are effective options, and the right choice depends on your health history, goals, and insurance coverage. Dr. Rakesh and Dr. Rachit Marwaha will guide you toward the most appropriate treatment after reviewing your history during your initial consultation.

Why Choose Naperville Internist for Tirzepatide in Naperville

Dr. Rakesh Marwaha and Dr. Rachit Marwaha are board-certified internal medicine physicians, and every tirzepatide plan they develop starts with a thorough in-person assessment. No prescription is written before that review is complete. Your protocol is built around your specific health status, current medications, and goals, not a standardized approach applied across all patients. Because Naperville Internist is a full internal medicine practice, conditions that commonly accompany excess weight, including insulin resistance, metabolic syndrome, and hypertension, can be diagnosed and treated in the same office without sending you to additional specialists.

What Our Patients Say About Naperville Internist

Patients consistently describe care at Naperville Internist as distinct from commercial weight loss programs: attentive, clinically grounded, and adapted to their individual situation. Results are in line with clinical data showing average weight loss of 20 to 22 percent of total body weight when tirzepatide is combined with dietary and lifestyle changes.

Frequently Asked Questions About Tirzepatide in Naperville

Who qualifies for tirzepatide treatment?

FDA approval covers adults with a BMI of 30 or higher, or 27 or higher with at least one qualifying condition such as type 2 diabetes or high blood pressure. Eligibility also depends on personal and family medical history, and the medication is contraindicated in patients with a history of medullary thyroid carcinoma or MEN2. Dr. Rakesh and Dr. Rachit Marwaha confirm eligibility through a full medical review at your first visit before any treatment plan is discussed.

How much weight can I expect to lose with tirzepatide?

Clinical trials show patients using tirzepatide alongside dietary and lifestyle modifications achieved average weight reductions of 20 to 22 percent of total body weight. Individual results vary based on starting weight, adherence to treatment, and overall health. Your physician will establish realistic milestones at the outset and adjust your plan as your progress develops over time.

What side effects are most common with tirzepatide injections?

The most frequently reported effects are gastrointestinal, including nausea, mild diarrhea, and reduced appetite, and they are most likely during the dose escalation phase of treatment. Starting at a lower dose and increasing gradually, which is how our protocol is structured, reduces both the likelihood and severity of these symptoms considerably. Most patients find they diminish as the body adjusts to the medication.

Is tirzepatide the same thing as Mounjaro or Zepbound?

Yes. Tirzepatide is the active ingredient in both Mounjaro, which is FDA-approved for type 2 diabetes, and Zepbound, which is FDA-approved specifically for chronic weight management in adults. When prescribing tirzepatide for weight loss, our physicians select the appropriate brand and formulation based on your diagnosis and insurance coverage, and will walk you through the distinction at your consultation.

Does insurance cover tirzepatide for weight loss?

Coverage varies significantly by carrier and plan. Some insurers cover GIP/GLP-1 medications when prescribed for type 2 diabetes management, while coverage specifically for chronic weight management is less consistent across plans. Our team will review your options at your appointment so you know what to expect before any prescription is written.

Start Tirzepatide Treatment in Naperville Today

Naperville Internist offers physician-supervised tirzepatide weight loss in Naperville, IL under the direct care of board-certified internal medicine physicians. Dr. Rakesh Marwaha and Dr. Rachit Marwaha will build a personalized treatment plan grounded in your health history and goals.

Virtual Consultations Now Available!